Middle East and Africa Multiplex Assays Market, By Products & Services (Reagents & Consumables, Instruments & Accessories, Software & Services), Type (Nucleic Acid Multiplex Assays, Protein Multiplex Assays, Cell-Based Multiplex Assays), Technology (Protein Microarray, Polymerase Chain Reaction, Multiplex Real-Time PCR, Flow Cytometry, Fluorescence Detection, Luminescence, Others), Application (Clinical Diagnostics, Research & Development), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Others), Country (Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Middle East and Africa Multiplex Assays Market
The multiplex assays market is expected to witness market growth at a rate of 6.5% in the forecast period of 2021 to 2028. Data Bridge Market Research report on multiplex assays market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in healthcare sector globally is escalating the growth of multiplex assays market.
A Multiplex Assay refers to a type of immunoassay that uses magnetic beads or non-magnetic beads for determining multiple analyte in a single sample. A multiplex assay is considered similar to that of an ELISA but here in multiplex assays, beads are present that are highly beneficial in binding the capture antibody.
The increase in the prevalence of breast cancer among women across the region acts as one of the major factors driving the growth of multiplex assays market. The launch of coronavirus PCR testing program for health facilities by the Saudi Center for Disease Prevention and Control, and extensive applications of multiplex PCR improving the diagnosis process accelerate the market growth. The high use of multiplex assays in companion diagnostics and increase in adoption of the technology owning to the advantages over singleplex and traditional assays further influence the market. Additionally, surge in investment, surge in healthcare expenditure, increasing geriatric population and growing awareness positively affects the multiplex assays market. Furthermore, need for high-throughput and automated systems and increase in validation of biomarkers in molecular and protein diagnostics extend profitable opportunity to the market players in the forecast period of 2021 to 2028.
On the other hand, high cost associated with the equipment is expected to obstruct the market growth. The presence of stringent regulations and standards is projected to challenge the multiplex assays market in the forecast period of 2021-2028.
This multiplex assays market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on multiplex assays market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Middle East and Africa Multiplex Assays Market Scope and Market Size
The multiplex assays market is segmented on the basis of products & services, type, technology, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product & services, the multiplex assays market is segmented into reagents & consumables, instruments & accessories and software and services.
- On the basis of type, the multiplex assays market is segmented into protein multiplex assays, nucleic acid multiplex assays and cell-based multiplex assays. Protein multiplex assays are sub-segmented into planar protein assays and bead-based protein assays. Nucleic acid multiplex assays are sub-segmented into planar nucleic acid assays and bead-based nucleic acid assays.
- On the basis of technology, the multiplex assays market is segmented into flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR, polymerase chain reaction (PCR), protein microarray and others.
- On the basis of application, the multiplex assays market is segmented into research & development and clinical diagnostics. Research & development is sub-segmented into drug discovery & development and biomarker discovery & validation. Clinical diagnostics is sub-segmented into infectious diseases, cancer, cardiovascular diseases, infectious diseases, autoimmune diseases, allergies, nervous system disorders, metabolism & endocrinology disorders and others.
- On the basis of end user, the multiplex assays market is segmented into pharmaceutical & biotechnology companies, research institutes, hospitals, clinical laboratories and others.
Middle East and Africa Multiplex Assays Market Country Level Analysis
The multiplex assays market is analyzed and market size insights and trends are provided by country, products & services, type, technology, application and end user as referenced above.
The countries covered in the Middle East and Africa multiplex assays market report are Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and Rest of Middle East and Africa.
Saudi Arabia dominates the Middle East and Africa multiplex assays market due to the increase in prevalence of breast cancer within the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare infrastructure growth installed base and new technology penetration
Middle East and Africa multiplex assays market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Middle East and Africa multiplex assays market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Middle East and Africa multiplex assays market. The data is available for historic period 2010-2019.
Competitive Landscape and Middle East and Africa Multiplex Assays Market Share Analysis
The multiplex assays market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to multiplex assays market.
The major players covered in the multiplex assays market report are BD, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Cepheid, Siemens AG, Hologic Inc., Luminex Corporation. , MESO SCALE DIAGNOSTICS, LLC., QIAGEN, PerkinElmer Inc. , Illumina, Inc. , AGENA BIOSCIENCE, INC. , Olink , Randox Laboratories Ltd., Bio-Techne. , Agilent Technologies, Agilent Technologies, Sysmex Corporation, among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-